Publications

Detecting cognitive changes in preclinical Alzheimer’s disease: a review of its feasibility.

Mortamais M, Ash JA, Harrison J, Kaye J, Kramer J, Randolph C, Pose C, Albala B, Ropacki M, Ritchie CW, Ritchie K.
Alzheimer’s & dementia: the journal of the Alzheimer’s Association. 2017
10.1016/j.jalz.2016.06.2365

Structural neuroimaging in preclinical dementia: from microstructural deficits and grey matter atrophy to macroscale connectomic changes.

Mak E, Gabel S, Mirette H, Su L, Williams GB, Waldman A, Wells K, Ritchie K, Ritchie C, O’Brien J.
Ageing research reviews. 2017
10.1016/j.arr.2016.10.001

The clinical picture of Alzheimer’s disease in the decade before diagnosis: clinical and biomarker trajectories.

Ritchie K, Carrière I, Berr C, Amieva H, Dartigues JF, Ancelin ML, Ritchie CW.
The Journal of clinical psychiatry. 2016
10.4088/JCP.15m09989

Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors.

Ritchie K, Carrière I, Ritchie CW, Berr C, Artero S, Ancelin ML.
BMJ. 2010
PMC2917002

Perspectives on Communicating Biomarker-Based Assessments of Alzheimer’s Disease to Cognitively Healthy Individuals.

Milne R, Bunnik E, Diaz A, Richard E, Badger S, Gove D, Georges J, Fauria K, Molinuevo JL, Wells K, Ritchie C.
Journal of Alzheimer’s Disease. 2018
10.3233/JAD-170813

PREVENT participants took part in organised group discussions around the benefits, harms and rights of an individual finding out information from biological measurements that may inform their personal risk of Alzheimer’s disease.

Read More